Indian markets see renewed investor interest in pharma, speciality chemicals, and exchange-traded services, with recent earnings showing mixed signals. Pharma valuations are attractive, with Sun Pharma and MNCs like GSK and Pfizer showing promise. Speciality chemicals require patience, while BSE’s performance is linked to market sentiment and NSE’s upcoming listing.
Mcap of 8 of top-10 firms erodes by Rs 1.55L cr
Recently, the market witnessed a downturn, with eight of the leading firms in India suffering major valuation losses. The declines of HDFC Bank and Bajaj